Shruti Bhat PhD, MBA, Lean Six Sigma Black Belt
  • Home
  • About Shruti
  • Consulting
  • Workshops
  • Patents
  • Articles
    • Case Studies
    • Innovation Portfolio Development & Patents
    • Drugs-in-the- making
    • Culture Change & Business Transformation
    • Operational Excellence, Quality & Continuous Improvement
  • Books
  • Digital
  • Blog
  • Videos
  • Contact

Drug Research and Technology Highlights

12/12/2009

0 Comments

 
Armodafinil relieves residual excessive sleepiness in patients with depression, OSA.
Researchers at the University of Southern Mississippi found Armodafinil (Nuvigil) may bring relief of residual excessive sleepiness to patients with depression and obstructive sleep apnea. The  study met only one of the two primary efficacy endpoints compared with placebo, with armodafinil increasing response in the overall clinical condition with regard to sleepiness (69 versus 53 percent). There were, however, "some significant improvements with armodafinil on secondary endpoints viz. scores on the Epworth Sleepiness Scale and the Functional Outcomes of Sleep Questionnaire improved in both groups, armodafinil was generally well-tolerated.

Study quantifies acne drug's link to IBD.
Roche Holding allegedly pulled its blockbuster drug Accutane [isotretinoin] off the market...amid early signs that the drug may be linked to inflammatory bowel disease (IBD) according to a study released last week. The study quantified those risks, finding that users of the medication have almost twice the odds of developing a serious bowel disorder as nonusers. However, for now, generic versions are still available, but the latest troubles could lead to the withdrawal of the controversial medication considered the treatment of last resort for acne so damaging it can lead to pitting of the face and a lifetime of anguish.

Plavix appears to work about as well in women as it does in men.
According to a report appearing in the Journal of the American College of Cardiology, unlike aspirin, clopidogrel (Plavix) appears to work about as well in women as it does in men. In fact, "clopidogrel reduced cardiovascular events by 7% in women and 16% in men compared with placebo, with only a 'weak' trend for a difference between genders." The researchers found that "major bleeding risk was elevated 43% in women and 22% in men compared with placebo, again without a significant difference.

Study expected to show Niaspan unclogs arteries better than Vytorin.
Merck & Co. may face a third negative study result within two years for its cholesterol pills Vytorin [ezetimibe and simvastatin] and Zetia [ezetimibe], which have lost 14 percent of sales since January and could sink further." Analysts said the latest trial's results are likely to show that Niaspan [niacin] unclogged arteries better than Vytorin.

New anti-inflammatory molecule may be safe.
In its first clinical test, a novel anti-inflammatory molecule targeting asthma and other conditions appears to be safe, even at relatively high doses," according to a UK scientist. In fact, the "safety profile for the compound, dubbed FX125L, 'couldn't be better.'" The investigational mix "is a broad-spectrum chemokine receptor inhibitor, taken orally, that targets a single receptor whose identity is still under wraps;  the receptor being  only expressed on a subset of leukocytes and only when inflammation is occurring, which should lead to very precise effects. Both in the laboratory and in animal studies, the drug blocked the migration of inflammatory cells."

Follow Shruti on Twitter, Facebook, YouTube, LinkedIn
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement

    New Book Released!

    top ten strategic decision-making tools for operational excellence

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    5S
    Agile
    Artificial Intelligence
    Automation
    Balanced Score Card
    Biotechnology
    Books
    Business Turnaround
    Case Studies
    Change Management
    Chemical Industry
    CMMI
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Food Industry
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    Nanotechnology
    Operations
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    Robotics
    Scrum
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    TQM
    Videos
    Voice Of Customer
    Workshops

    Shruti's books...

    Picture
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    Picture
    how to overcome challenges of creating effective teams
    how to lead a successful business transformation

    ​Micro-Learning
    ​Partner

    Picture

    Publishing Partner

    fast read books, business management books, health and wellness books, spiritual guidance books, best online book store

    Wellness
    ​Partner

    Picture
© Copyright 1992- 2022 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media